// App-Quantinova.ai

1493 : Longitudinal comparison of 11C-PE2I and 18F-DOPA PET for assessing severity and rate of disease progression in patients with Parkinson’s disease

Researchers

Presenter

  • W. Li

Principal Investigators

  • N. Lao-Kaim

  • A.-A. Roussakis

  • A. Martin-Bastida

  • C. Loane

  • N. Valle-Guzman

  • Z. Kefalopoulou

  • M. Politis

  • T. Foltynie

  • R. Barker

  • P. Piccini

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved